Take part in a hair regrowth study.
Millions of men and women have androgenetic alopecia—the most common form of hair loss.
You may be able to take part in a clinical trial evaluating an investigational treatment that doctors and researchers are studying to see whether it may help with hair loss and support hair regrowth.
The trial is now enrolling in Melbourne, Brisbane, and Sydney.
The HEADLINE trial is a clinical trial evaluating the safety of the study drug, an investigational monoclonal antibody, in healthy adults with and without androgenetic alopecia (male and female pattern hair loss). The trial will also collect early information on how the investigational treatment may support hair growth in people with androgenetic alopecia.
The study drug is being investigated in ongoing clinical trials, and is not approved by the FDA or any other countries’ health or regulatory authority for the population or indication being investigated. This means that the safety and efficacy of the investigational treatment is still being studied in clinical trials.
This trial is being conducted by Absci, a biotechnology company developing treatments with the goal of developing potentially transformative treatments for diseases like androgenetic alopecia.
Professor Dr. Rodney Sinclair, world-renowned dermatologist and researcher on hair-loss, is one of the experts helping lead the way.
By participating in the HEADLINE trial, you may gain access to the latest research on a potential new treatment for androgenetic alopecia, along with trial-related care from experienced doctors and dermatology research teams.
Receive trial-related care from experienced doctors and dermatology research teams.
There is no cost for participating, and you may be eligible to receive compensation.
Help researchers explore a potential new treatment for hair loss backed by biotech innovation.
Final eligibility is determined by the clinical trial team.
(not an exhaustive list and final eligibility is determined by the clinical trial team)
Certain significant medical conditions or recent major surgery/injury.
Certain infections (such as HIV, hepatitis B or C), hormone/endocrine conditions, or high-risk cardiovascular profiles.
Recent or current use of hair-loss medications or procedures, or recent hair transplants or major scalp procedures.
Scalp skin conditions that could interfere with hair assessments.
Are an adult aged 18–65 in generally good health.
Are with or without androgenetic alopecia (male or female pattern hair loss)
Are willing to keep your hair length consistent and avoid certain hair and scalp products during the trial.
Are not pregnant or breastfeeding and are willing to follow contraception guidance if applicable.
Scroll down to complete a short online form. This helps the team see whether you may be eligible to participate.
If you may be eligible, a coordinator will contact you to review the trial in detail, answer questions, and, if you choose to continue, guide you through the informed consent process.
You'll attend an in-person screening visit for health checks, hair/scalp assessments, blood samples, and routine tests to confirm eligibility.
If you qualify, you’ll take part in scheduled trial visits. Some participants may have a short in‑clinic stay; your team will explain the schedule before you decide.
There is no cost for you to participate in the trial. Additionally, you may be eligible to receive compensation and your trial team will be available to support you. You can leave the trial at any time.
Scroll down to complete a short online form. This helps the team see whether you may be eligible to participate.
If you may be eligible, a coordinator will contact you to review the trial in detail, answer questions, and, if you choose to continue, guide you through the informed consent process.
You'll attend an in-person screening visit for health checks, hair/scalp assessments, blood samples, and routine tests to confirm eligibility.
If you qualify, you’ll take part in scheduled trial visits. Some participants may have a short in‑clinic stay; your team will explain the schedule before you decide.
There is no cost for you to participate in the trial. Additionally, you may be eligible to receive compensation and your trial team will be available to support you. You can leave the trial at any time.
Find a participating site
Nucleus Network Melbourne
Sinclair Dermatology
Nucleus Network Brisbane
Momentum Clinical Research St Leonards
Don't see a convenient location? More sites may open soon. Complete the "See If You Qualify" form below to join the waitlist.
Answer a few questions to see whether you may be eligible for the HEADLINE trial. If you may qualify, a trial coordinator will contact you to discuss next steps and schedule a screening visit at a participating site.